McKelligon Brian

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$453,550.71

Insider Activity of McKelligon Brian

According to the SEC Form 4 filings, McKelligon Brian, being in a position of

  1. President and CEO at Akoya Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 52500 shares for $203,317,
    over all time since 2022-06-15, has bought 0 shares, and sold 77500 shares for $453,551.

The largest sale of all time was on 2022-09-07 and amounted to 5000 shares of Akoya Biosciences, Inc. for $64,170.

Biography of McKelligon Brian

No biography is available at this moment.

2024-06-11SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0145%
$2.08$15,630+10.73%
2024-06-06SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0146%
$2.01$15,064+15.31%
2024-03-20SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.015%
$4.97$37,243-47.62%
2024-03-13SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0155%
$4.94$37,043-44.9%
2023-12-19SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0146%
$4.48$33,566-14.68%
2023-12-12SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0152%
$4.25$31,871-5.52%
2023-11-20SaleAkoya Biosciences, Inc.
AKYA
President and CEO
7,500
0.0155%
$4.39$32,901-4.1%
2023-06-06SaleAkoya Biosciences, Inc.
AKYA
President/CEO
5,000
0.0131%
$5.71$28,537-16.67%
2023-03-14SaleAkoya Biosciences, Inc.
AKYA
President/CEO
5,000
0.0135%
$9.17$45,852-39.18%
2022-12-06SaleAkoya Biosciences, Inc.
AKYA
President/CEO
5,000
0.0129%
$12.08$60,415-44.92%
2022-09-07SaleAkoya Biosciences, Inc.
AKYA
President/CEO
5,000
0.0133%
$12.83$64,170-27.69%
2022-06-15SaleAkoya Biosciences, Inc.
AKYA
President/CEO
5,000
0.0131%
$10.25$51,260+12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.